Ascendis Pharma A ASND
NASDAQ ASND
$238.90 +4.57 (+1.95%)
At close: Oct 21, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Payables (2012 - 2026)

Updated

Ascendis Pharma A (ASND) posted Payables of $120.79 million for the quarter ended Jun 30, 2026, up 13.9% from $106.08 million a year earlier but down 77.8% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Payables (2012 - 2026) Analysis & Trends

As of Dec 31, 2025, Ascendis Pharma A's Payables came in at $102.43 million, down 1.8% from the prior year.

  • Annual Payables shows a five-year compound annual growth rate of 31.4% (years ended Dec 2020 to Dec 2025).
  • In prior years, Ascendis Pharma A's Payables was $104.33 million in the year ended Dec 31, 2024 (+2.0%), $102.29 million in the year ended Dec 31, 2023 (-3.9%), $106.48 million in the year ended Dec 31, 2022 (+56.7%) and $67.97 million in the year ended Dec 31, 2021 (+160.4%).
  • Quarterly Payables has run from a low of $67.97 million in the quarter ended Dec 31, 2021 to a high of $544.04 million in the quarter ended Mar 31, 2026 over five years.
  • On a year-over-year basis, Payables has increased in each of the last four quarters, with growth averaging 61.2% over the last eight quarters.
  • The strongest year-over-year quarter for Payables in the past five years was the quarter ended Mar 31, 2026, with growth of 513.0%; the weakest was the quarter ended Sep 30, 2024, with a decline of 37.5%.
  • According to Business Quant data, Payables for the three prior quarters was $544.04 million (quarter ended Mar 31, 2026), $105.53 million (quarter ended Dec 31, 2025) and $91.89 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 20.92 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 33.30 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.96 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 22.89 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 674.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 7.03 Bn
10 Ascendis Pharma A 14.48 Bn 10.74 Bn 362.22 Mn 118.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 118.70 Mn
Mar 31, 2026 532.54 Mn
Dec 31, 2025 610.92 Mn
Sep 30, 2025 592.25 Mn
Jun 30, 2025 600.20 Mn
Mar 31, 2025 577.92 Mn
Dec 31, 2024 577.13 Mn
Sep 30, 2024 555.51 Mn
Jun 30, 2024 569.39 Mn
Mar 31, 2024 560.78 Mn
Dec 31, 2023 555.25 Mn
Sep 30, 2023 140.88 Mn
Jun 30, 2023 161.59 Mn
Mar 31, 2023 171.02 Mn
Dec 31, 2022 120.11 Mn
Sep 30, 2022 104.39 Mn
Jun 30, 2022 93.04 Mn
Mar 31, 2022 88.86 Mn
Dec 31, 2021 75.21 Mn
Sep 30, 2021 88.72 Mn
API Access

Ascendis Pharma A Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=ASND&period=max&api_key=YOUR_API_KEY